Class information for:
Level 1: LEVETIRACETAM//SV2A//BRIVARACETAM

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
12990 804 29.5 82%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
46 30816 EPILEPSY//EPILEPSIA//ANTIEPILEPTIC DRUGS

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 LEVETIRACETAM Author keyword 335 51% 58% 466
2 SV2A Author keyword 54 83% 4% 30
3 BRIVARACETAM Author keyword 31 73% 3% 24
4 UCB L059 Author keyword 21 90% 1% 9
5 KEPPRA Author keyword 21 65% 2% 20
6 SYNAPTIC VESICLE PROTEIN 2A Author keyword 17 100% 1% 8
7 LEVETIRACETAM LEV Author keyword 14 100% 1% 7
8 UCB 34714 Author keyword 14 100% 1% 7
9 LEVETIRACETAM KEPPRA Author keyword 12 86% 1% 6
10 SYNAPTIC VESICLE PROTEIN 2A SV2A Author keyword 6 80% 0% 4

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 LEVETIRACETAM 335 51% 58% 466 Search LEVETIRACETAM Search LEVETIRACETAM
2 SV2A 54 83% 4% 30 Search SV2A Search SV2A
3 BRIVARACETAM 31 73% 3% 24 Search BRIVARACETAM Search BRIVARACETAM
4 UCB L059 21 90% 1% 9 Search UCB+L059 Search UCB+L059
5 KEPPRA 21 65% 2% 20 Search KEPPRA Search KEPPRA
6 SYNAPTIC VESICLE PROTEIN 2A 17 100% 1% 8 Search SYNAPTIC+VESICLE+PROTEIN+2A Search SYNAPTIC+VESICLE+PROTEIN+2A
7 LEVETIRACETAM LEV 14 100% 1% 7 Search LEVETIRACETAM+LEV Search LEVETIRACETAM+LEV
8 UCB 34714 14 100% 1% 7 Search UCB+34714 Search UCB+34714
9 LEVETIRACETAM KEPPRA 12 86% 1% 6 Search LEVETIRACETAM+KEPPRA Search LEVETIRACETAM+KEPPRA
10 SYNAPTIC VESICLE PROTEIN 2A SV2A 6 80% 0% 4 Search SYNAPTIC+VESICLE+PROTEIN+2A+SV2A Search SYNAPTIC+VESICLE+PROTEIN+2A+SV2A

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 UCB L059 174 83% 12% 98
2 ANTIEPILEPTIC DRUG LEVETIRACETAM 129 67% 14% 116
3 REFRACTORY PARTIAL SEIZURES 101 51% 18% 142
4 ANTICONVULSANT LEVETIRACETAM 73 96% 3% 23
5 CNS PHARMACODYNAMICS 45 94% 2% 16
6 SV2A LIGAND 30 100% 1% 12
7 ADJUNCTIVE BRIVARACETAM 27 92% 1% 11
8 SV2A 27 66% 3% 25
9 ADJUNCTIVE LEVETIRACETAM 23 74% 2% 17
10 ANTICONVULSANT DRUG 19 36% 5% 43

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Levetiracetam A Review of its Use in Epilepsy 2011 41 115 65%
Brivaracetam for the treatment of epilepsy in adults 2014 5 35 54%
Levetiracetam: a comprehensive review 2010 31 92 66%
Clinical pharmacokinetics of levetiracetam 2004 158 54 67%
Levetiracetam: Part II, the clinical profile of a novel anticonvulsant drug 2007 44 55 76%
The adverse effects profile of levetiracetam in epilepsy: a more detailed look 2014 1 20 100%
Safety and efficacy of levetiracetam for the treatment of partial onset seizures in children from one month of age 2013 5 73 70%
Levetiracetam for managing neurologic and psychiatric disorders 2009 23 94 63%
Levetiracetam in pediatrics 2005 25 29 93%
Behavioral side-effects of levetiracetam in children with epilepsy: A systematic review 2014 1 44 84%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 PHARMA SECTOR 5 27% 2.0% 16
2 PHARMACOL THER EUT UNIT 4 23% 1.7% 14
3 PRECLIN CNS 2 14% 2.1% 17
4 CHEMIN FORIEST 2 33% 0.7% 6
5 PHARMA SECTOR DEV 2 67% 0.2% 2
6 SGS LIFE SCI SERV 2 67% 0.2% 2
7 CLIN EPIDEMIOL OUTCOMES UNIT 1 50% 0.2% 2
8 GLOBAL PHARMACOMET 1 100% 0.2% 2
9 NEUROL PHARM 1 100% 0.2% 2
10 UCB CNS INNOVAT 1 100% 0.2% 2

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000200438 LAMOTRIGINE//FELBAMATE//OXCARBAZEPINE
2 0.0000167499 LACOSAMIDE//ESLICARBAZEPINE ACETATE//PERAMPANEL
3 0.0000128435 ZITTER RAT//ATTRACTIN//SPONTANEOUSLY EPILEPTIC RAT SER
4 0.0000126367 TOPIRAMATE//TOPIRAMATE TOPAMAX//TOPIRAMATE TOXICITY
5 0.0000114440 LATE ONSET SEIZURES//STROKE RELATED SEIZURES//POST STROKE EPILEPSY
6 0.0000101703 ZONISAMIDE//NEUROSCI MOL BIOL//CA2 INDUCED CA2 RELEASING SYSTEM
7 0.0000088104 VET MED D426//VET EXTRA NEUROL//BROMIDE INTOXICATION
8 0.0000083756 POSTTRAUMATIC EPILEPSY//POST TRAUMATIC EPILEPSY//POST TRAUMATIC SEIZURES
9 0.0000073301 STATUS EPILEPTICUS//NONCONVULSIVE STATUS EPILEPTICUS//REFRACTORY STATUS EPILEPTICUS
10 0.0000072218 ANTICONVULSANT ACTIVITY//MES TEST//EPILEPSY BRANCH